MA11.07 Phase 1/2 TRIDENT-1 Study of Repotrectinib in Patients with ROS1+ or NTRK+ Advanced Solid Tumors

B.C. Cho, Robert Doebele, J. Lin, Misako Nagasaka, C. Baik, A. Wekken, Vamsidhar Velcheti, Ki Hyeong Lee, Liu Jik, Berhanu Solomon, S. Kao, Matthew Krebs, V. Zhu, S. Stopatschinskaja, Ross Camidge, Alexander Edward Drilon

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S174-S175
JournalJournal of Thoracic Oncology
Volume16
DOIs
Publication statusPublished - 1 Mar 2021

Cite this